CN104364658B - 用于诊断慢性瓣膜疾病的方法 - Google Patents

用于诊断慢性瓣膜疾病的方法 Download PDF

Info

Publication number
CN104364658B
CN104364658B CN201380029514.3A CN201380029514A CN104364658B CN 104364658 B CN104364658 B CN 104364658B CN 201380029514 A CN201380029514 A CN 201380029514A CN 104364658 B CN104364658 B CN 104364658B
Authority
CN
China
Prior art keywords
sample
valvular disease
metabolin
animal
chronic valvular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380029514.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN104364658A (zh
Inventor
Q·李
D·P·拉弗莱姆
S·S·汉娜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe dAssistance Technique pour Produits Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dAssistance Technique pour Produits Nestle SA filed Critical Societe dAssistance Technique pour Produits Nestle SA
Publication of CN104364658A publication Critical patent/CN104364658A/zh
Application granted granted Critical
Publication of CN104364658B publication Critical patent/CN104364658B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G01N33/5758—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/491—Blood by separating the blood components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/326—Arrhythmias, e.g. ventricular fibrillation, tachycardia, atrioventricular block, torsade de pointes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/16—Phosphorus containing
    • Y10T436/163333—Organic [e.g., chemical warfare agents, insecticides, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666—Carboxylic acid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
CN201380029514.3A 2012-06-05 2013-06-04 用于诊断慢性瓣膜疾病的方法 Active CN104364658B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261655704P 2012-06-05 2012-06-05
US61/655,704 2012-06-05
PCT/US2013/044008 WO2013184628A1 (en) 2012-06-05 2013-06-04 Methods for diagnosing chronic valvular disease

Publications (2)

Publication Number Publication Date
CN104364658A CN104364658A (zh) 2015-02-18
CN104364658B true CN104364658B (zh) 2017-06-30

Family

ID=48626663

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380029514.3A Active CN104364658B (zh) 2012-06-05 2013-06-04 用于诊断慢性瓣膜疾病的方法

Country Status (12)

Country Link
US (1) US20150153353A1 (enExample)
EP (1) EP2856170B1 (enExample)
JP (1) JP6174689B2 (enExample)
CN (1) CN104364658B (enExample)
AU (1) AU2013271879B2 (enExample)
BR (1) BR112014030243B1 (enExample)
CA (1) CA2875331C (enExample)
ES (1) ES2687979T3 (enExample)
IN (1) IN2014DN10127A (enExample)
MX (1) MX358561B (enExample)
RU (1) RU2667634C2 (enExample)
WO (1) WO2013184628A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10184932B2 (en) * 2015-12-07 2019-01-22 Zora Biosciences Oy Use of ceramides and LPLs in diagnosing CVD

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101951924A (zh) * 2007-11-09 2011-01-19 得克萨斯系统大学董事会 Mir-15家族的微小rna调控心肌细胞存活和心脏修复
CN102016575A (zh) * 2008-05-07 2011-04-13 斯特拉斯克莱德大学 细胞表征的系统和方法
CN102119332A (zh) * 2008-04-29 2011-07-06 免疫刺激公司 免疫调节组合物及其使用方法
CN102369217A (zh) * 2009-01-29 2012-03-07 雅培制药有限公司 Il-1结合蛋白

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257943A1 (en) * 2005-01-25 2006-11-16 Cis Biotech, Inc. Ischemic biomarkers and their use to predict adverse neurological events from surgery
EP2164977B1 (en) * 2007-07-17 2013-10-30 Metabolon, Inc. Biomarkers for pre-diabetes and methods using the same
MX2013000917A (es) * 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101951924A (zh) * 2007-11-09 2011-01-19 得克萨斯系统大学董事会 Mir-15家族的微小rna调控心肌细胞存活和心脏修复
CN102119332A (zh) * 2008-04-29 2011-07-06 免疫刺激公司 免疫调节组合物及其使用方法
CN102016575A (zh) * 2008-05-07 2011-04-13 斯特拉斯克莱德大学 细胞表征的系统和方法
CN102369217A (zh) * 2009-01-29 2012-03-07 雅培制药有限公司 Il-1结合蛋白

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease;Zengeng Wang,et al.;《Nature》;20110407;第472卷;第57-65页 *

Also Published As

Publication number Publication date
ES2687979T3 (es) 2018-10-30
RU2014153109A (ru) 2016-08-10
JP6174689B2 (ja) 2017-08-02
MX2014014791A (es) 2015-02-24
AU2013271879B2 (en) 2019-03-28
RU2667634C2 (ru) 2018-09-21
CA2875331A1 (en) 2013-12-12
WO2013184628A1 (en) 2013-12-12
AU2013271879A1 (en) 2014-12-18
IN2014DN10127A (enExample) 2015-08-21
CA2875331C (en) 2022-11-29
BR112014030243B1 (pt) 2022-07-05
US20150153353A1 (en) 2015-06-04
EP2856170B1 (en) 2018-07-25
BR112014030243A2 (pt) 2017-06-27
MX358561B (es) 2018-08-24
JP2015524066A (ja) 2015-08-20
CN104364658A (zh) 2015-02-18
EP2856170A1 (en) 2015-04-08

Similar Documents

Publication Publication Date Title
Khamis et al. Mass spectrometric based approaches in urine metabolomics and biomarker discovery
CA2911204C (en) Biomarkers related to kidney function and methods using the same
Kim et al. Mass spectrometry-based metabolomics in translational research
Naz et al. Method development and validation for rat serum fingerprinting with CE–MS: application to ventilator-induced-lung-injury study
JP6763770B2 (ja) 自閉症スペクトラム障害のバイオマーカー
Snowden et al. Application of metabolomics approaches to the study of respiratory diseases
US20200191768A1 (en) Biomarker for diagnosing depression and use of biomarker
Kuehnbaum et al. Multiplexed separations for biomarker discovery in metabolomics: Elucidating adaptive responses to exercise training
JP5977795B2 (ja) 多発性硬化症を診断するための生物マーカー、及びその方法
Suzuki et al. Metabolome analysis for discovering biomarkers of gastroenterological cancer
WO2015179952A1 (en) A metabolite panel for improved screening and diagnostic testing of cystic fibrosis
JP5522365B2 (ja) 代謝物の異常度の取得方法、代謝異常の判定方法、及びそのプログラム、並びに、代謝物の異常度の取得装置、及び代謝異常の判定に基づく診断プログラム
CN112305121B (zh) 代谢标志物在动脉粥样硬化性脑梗死中的应用
JP2009175141A (ja) 化合物のスクリーニング方法
CN104364658B (zh) 用于诊断慢性瓣膜疾病的方法
US20240352542A1 (en) Means and methods for diagnosing a viral infection or a disease associated therewith
KR20220162918A (ko) 아실카르니틴 대사체를 포함하는 구강암 진단용 바이오마커 조성물
WO2015183917A2 (en) Metabolic biomarkers for memory loss
TWI858977B (zh) 生物標記物組、為個體提供老化標記物水平表示的方法、用於提供對個體的生物年齡預測的方法及套組
JP7748047B2 (ja) 唾液中のうつ病バイオマーカー
CN112305123B (zh) 小分子物质在动脉粥样硬化性脑梗死中的应用
Xu Liquid chromatography-mass spectrometry based metabolomics, lipidomics and epitranscriptomics.
Chen Development of bioinformatics solutions to enable hair-based exposome research
US20200232995A1 (en) Measurement of protein molecular flux rates by quantifying isotopologue abundances in immonium ion using high resolution mass spectrometry
Abou Elhassan et al. Aging-linked systemic lipid signature is reprogrammed by caloric restriction in rhesus monkeys

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20190724

Address after: Vevey

Patentee after: SOCIETE DES PRODUITS NESTLE S. A.

Address before: Vevey

Patentee before: Nestle Products Technical Assistance Co., Ltd.